Skip to content

Diabetes Treatment in China: Top Hospitals for International Patients

Diabetes treatment in China at Huashan Hospital with insulin and glucose testing equipment.

Most of China’s top diabetes teams work in big public hospitals linked to medical schools, in many cities. This guide lists hospitals with a strong diabetes (endocrinology) department. Either the government has named the department a national key specialty, or the hospital states its result in a national specialty ranking on its own official account. It also shows which modern medicines, devices and surgery are approved in China.

Key points
  • We list a hospital when the government has named its endocrinology department a national clinical key specialty. We also list it when the hospital itself states its result in a national specialty ranking. Every claim links to its source.
  • A chief physician consultation at a top public hospital typically costs about ¥31 (¥12–¥80 across 12 provinces), from official price lists checked in November 2026.
  • An HbA1c blood test costs about ¥30; a bed in a three-bed hospital room is about ¥64 a day.
  • Newer medicines such as semaglutide (injection and tablets), tirzepatide, dulaglutide and dapagliflozin are approved in China.

How we choose these hospitals

We list hospitals in two ways. First, departments the government has named national clinical key specialties for endocrinology, where we found the official notice. Second, hospitals that state on their own official WeChat account how their endocrinology department did in a national specialty ranking. We quote the hospital and link to its post. We make no ranking of our own.

Top hospitals for diabetes, by city

Beijing

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Peking Union Medical College Hospital
中国医学科学院北京协和医院
National clinical key specialty construction project“1988年,在史轶蘩教授的主持下,始创于1924年的协和代谢实验室获批成为卫生部内分泌重点实验室”
In 1988, led by Professor Shi Yifan, the hospital’s metabolism laboratory (founded in 1924) became a Ministry of Health key laboratory for endocrinology. (our translation · hospital’s own WeChat post, 2021-08-16)
Peking University First Hospital
北京大学第一医院
National clinical key specialty construction project“还与院内外其它专业科室合作,开设了甲状腺疾病、甲状腺相关眼病、肾上腺疾病、糖尿病足病、高雄激素血症和肿瘤免疫治疗(PD-1)相关内分泌不良反应等多学科专家联合会诊中心”
With other departments, it runs joint expert clinics for thyroid disease, thyroid eye disease, adrenal disease, diabetic foot, high male hormone levels and hormone side effects of cancer immunotherapy (PD-1). (our translation · hospital’s own WeChat post, 2020-03-13)
Peking University Third Hospital
北京大学第三医院
National clinical key specialty construction project“牵头成立糖尿病诊治海淀区专科联盟,北医三院糖尿病“一站式”诊疗中心正式揭牌”
It led the founding of a diabetes care alliance in Haidian district and opened a one-stop diabetes care centre. (our translation · hospital’s own WeChat post, 2024-12-31)
Beijing Hospital
北京医院
National clinical key specialty construction project“在以老年病为重点的相关疾病的诊治如糖尿病、帕金森氏病、冠心病的内外科治疗、脑血管疾病的介入治疗、老年痴呆、前列腺疾病、骨关节病、肺部感染、重症肌无力等方面处于国内领先水平”
In diseases of older people, such as diabetes, Parkinson’s disease, heart disease, stroke, dementia and joint disease, its care is at a leading level in China. (our translation · hospital’s own WeChat post, 2025-06-10)
Peking University People's Hospital
北京大学人民医院
National clinical key specialty construction project“北京大学人民医院内分泌科于1986年建科,2011年获得国家卫生健康委员会重点专科建设项目,是北京市唯一一家“北京市糖尿病临床医学研究中心”,也是国家代谢性疾病临床医学研究中心北京分中心”
The endocrinology department opened in 1986. In 2011 it became a National Health Commission key specialty construction project. It is Beijing’s only clinical research centre for diabetes, and the Beijing branch of the national clinical research centre for metabolic diseases. (our translation · hospital’s own WeChat post, 2022-08-02)

Shanghai

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
上海交通大学医学院附属瑞金医院
National clinical key specialty“瑞金医院内分泌代谢病学科为国家首批博士、硕士学位授予点,为国家卫健委内分泌代谢病重点实验室、国家临床重点专科和国家代谢性疾病临床医学研究中心,连续11年为复旦版全国专科声誉排行版(内分泌专业)第一名。”
The hospital’s endocrinology and metabolism department was among the first in China allowed to award doctoral and master’s degrees. It hosts a National Health Commission key laboratory for endocrine and metabolic diseases, a national clinical key specialty and the national clinical research centre for metabolic diseases. It has been first in the Fudan national specialty reputation ranking (endocrinology) for 11 years in a row. (our translation · hospital’s own WeChat post, 2022-05-15)
Huashan Hospital, Fudan University
复旦大学附属华山医院
National clinical key specialty“内分泌科新开辟糖尿病足病房,成立糖尿病足医疗组,规范会诊转诊流程,专病专治,快速推进患者诊治。”
The endocrinology department opened a new diabetic foot ward and set up a diabetic foot team, with clear steps for consultations and referrals. (our translation · hospital’s own WeChat post, 2023-02-16)
Shanghai Sixth People's Hospital
上海市第六人民医院
National clinical key specialty“上海市第六人民医院减重代谢外科开展代谢手术已10余年,是国内手术例数最多,成果最丰富的单位之一”
Its weight-loss and metabolic surgery department has done metabolic surgery for more than 10 years. It is one of the units in China with the most operations and results. (our translation · hospital’s own WeChat post, 2023-10-09)
Jinan (2)

Jinan

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Shandong Provincial Hospital Affiliated to Shandong First Medical University
山东第一医科大学附属省立医院
National clinical key specialty“先后开展膝下动脉腔内成形术治疗糖尿病足、胰岛素3C治疗、超声引导下甲状腺结节穿刺、甲状腺结节射频消融术、磁共振水脂分离技术评估胰腺脂肪沉积等多项特色诊疗技术”
It has started special treatments such as below-knee artery angioplasty for diabetic foot, insulin 3C therapy, ultrasound-guided thyroid nodule biopsy, radiofrequency ablation of thyroid nodules and MRI to measure fat in the pancreas. (our translation · hospital’s own WeChat post, 2019-11-11)
Qilu Hospital of Shandong University
山东大学齐鲁医院
National clinical key specialty“目前已获批国家糖尿病规范化诊治中心、国家卫生健康委基层医师糖尿病管理实训中心、全国糖尿病健康管理示范单位、国家标准化代谢性疾病管理中心等多个国家级平台项目”
It holds several national programmes. These include a national centre for standard diabetes care, a training centre in diabetes care for local doctors, a national model unit for diabetes health management and a national metabolic disease management centre (MMC). (our translation · hospital’s own WeChat post, 2023-11-24)
Nanjing (2)

Nanjing

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Jiangsu Province Hospital
江苏省人民医院
National clinical key specialty“内分泌科杨涛教授率领的研究团队建立了包括发病年龄、BMI和胰岛功能在内的1型糖尿病临床诊断模型”
A research team led by Professor Yang Tao in the endocrinology department built a model to diagnose type 1 diabetes. It uses age at onset, BMI and how well the pancreas makes insulin. (our translation · hospital’s own WeChat post, 2017-09-17)
Nanjing Drum Tower Hospital
南京鼓楼医院
National clinical key specialty“南京鼓楼医院南部院区西六病区(血管重建与创面修复中心&糖尿病足诊疗中心)启用,国家临床重点专科内分泌科、省临床重点专科整形烧伤科正式入驻”
A new ward for blood vessel repair, wound repair and diabetic foot care opened at the hospital’s south campus. Its endocrinology department, a national clinical key specialty, works there with plastic and burns surgery. (our translation · hospital’s own WeChat post, 2025-08-28)
Changchun (1)

Changchun

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The First Bethune Hospital of Jilin University
吉林大学第一医院
National clinical key specialty construction project“对Wolfram综合征、卟啉病、MODY、Werner综合征、血色病等近50种内分泌代谢罕见病、疑难病的高效精准诊治,使得吉大一院内分泌代谢科的诊疗能力享誉全国。”
The department diagnoses and treats nearly 50 rare and complex endocrine and metabolic diseases, such as Wolfram syndrome, porphyria, MODY, Werner syndrome and haemochromatosis. This has made it known across China. (our translation · hospital’s own WeChat post, 2023-03-14)
Changsha (1)

Changsha

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The Second Xiangya Hospital of Central South University
中南大学湘雅二医院
National clinical key specialty“目前,代谢内分泌科是国家重点学科、教育部重点实验室、国家临床重点专科、国家临床医学研究中心。”
Today the metabolism and endocrinology department is a national key discipline, a Ministry of Education key laboratory, a national clinical key specialty and a national clinical research centre. (our translation · hospital’s own WeChat post, 2023-08-04)
Chengdu (1)

Chengdu

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
West China Hospital, Sichuan University
四川大学华西医院
National clinical key specialty construction project“华西医院第一个MDT诊治中心—糖尿病足诊治中心于2005年成立,在国内较早建立由内分泌代谢科牵头开展多学科协作、医护一体化的糖尿病足诊治模式。”
The hospital’s first multidisciplinary (MDT) centre, for diabetic foot, opened in 2005. It was one of the first in China where endocrinology leads a joint team of doctors and nurses for diabetic foot care. (our translation · hospital’s own WeChat post, 2026-06-08)
Chongqing (1)

Chongqing

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The First Affiliated Hospital of Chongqing Medical University
重庆医科大学附属第一医院
National clinical key specialty“来自同行的评价:在复旦排名2023年度西南地区专科声誉排行榜中,内分泌科位列第二,在中国医院专科声誉排行榜中获得提名。”
From its peers: in the Fudan 2023 Southwest regional specialty reputation ranking, its endocrinology department is second. It was also nominated in the China hospital specialty reputation ranking. (our translation · hospital’s own WeChat post, 2025-01-27)
Guangzhou (1)

Guangzhou

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
中山大学孙逸仙纪念医院
National clinical key specialty“中山大学孙逸仙纪念医院糖尿病足诊治中心隶属于中山大学孙逸仙纪念医院内分泌科,该科在国内率先开展了糖尿病足综合防治研究和临床诊疗项目”
The hospital’s diabetic foot centre is part of its endocrinology department. The department was among the first in China to combine research, prevention and treatment for diabetic foot. (our translation · hospital’s own WeChat post, 2019-09-21)
Hangzhou (1)

Hangzhou

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The Second Affiliated Hospital, Zhejiang University School of Medicine
浙江大学医学院附属第二医院
Not yet confirmed“复旦版《2023年度中国医院专科声誉排行榜》发布。浙大二院内分泌科再次上榜提名内分泌专科声誉全国排行榜,是浙江省唯一获得此殊荣的内分泌专科。”
The Fudan 2023 China hospital specialty reputation ranking was published. The hospital’s endocrinology department was again nominated in the national endocrinology reputation ranking. It is the only endocrinology department in Zhejiang Province with this honour. (our translation · hospital’s own WeChat post, 2024-11-26)
Shenyang (1)

Shenyang

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The First Hospital of China Medical University
中国医科大学附属第一医院
National clinical key specialty“我院8个专科进入全国前十名,14个专科获提名。 全国前十名 检验医学(第1)、全科医学(第3)、内分泌科(第5)”
In the 2021 Fudan specialty reputation ranking, eight of the hospital’s specialties were in the national top ten, including endocrinology (5th). (our translation · hospital’s own WeChat post, 2022-11-20)
Tianjin (1)

Tianjin

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Tianjin Medical University Chu Hsien-I Memorial Hospital
天津医科大学朱宪彝纪念医院
National clinical key specialty construction project“获批国家临床重点专科(代谢性疾病综合治疗)建设项目和国家代谢性疾病临床医学研究中心分中心”
It is a national clinical key specialty construction project (combined treatment of metabolic diseases) and a branch of the national clinical research centre for metabolic diseases. (our translation · hospital’s own WeChat post, 2026-06-10)
Wuhan (1)

Wuhan

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
Wuhan Union Hospital
华中科技大学同济医学院附属协和医院
National clinical key specialty“协和医院内分泌科是华中地区久负盛名的内分泌代谢性疾病诊治科室,是2011年华中地区唯一入选的国家卫健委首批内分泌临床重点专科、国家代谢病临床医学研究中心湖北省分中心”
The endocrinology department is well known in central China. In 2011 it was the only one in central China in the first group of national endocrinology clinical key specialties. It is also the Hubei branch of the national clinical research centre for metabolic diseases. (our translation · hospital’s own WeChat post, 2023-09-15)
Xi'an (1)

Xi'an

Swipe the table sideways to see all columns.

HospitalNational key specialty (endocrinology)Hospital’s own statement
The First Affiliated Hospital of Xi'an Jiaotong University
西安交通大学第一附属医院
National clinical key specialty construction project“科室同时也是国家内分泌代谢病临床研究中心陕西分中心、陕西省内分泌代谢病临床研究中心、陕西省内分泌代谢病临床质量控制中心及陕西省临床重点专科。”
The department is also the Shaanxi branch of the national clinical research centre for endocrine and metabolic diseases. It is Shaanxi’s clinical research centre and quality control centre for these diseases, and a Shaanxi clinical key specialty. (our translation · hospital’s own WeChat post, 2023-08-11)

“Not yet confirmed” means we have not yet found the official notice. It does not mean the department lacks the title.

Treatments available in China

Leading hospitals in China treat diabetes by the national guidelines of the Chinese Diabetes Society. The current edition is the Guideline for the Prevention and Treatment of Diabetes in China (2024 edition). China also has its own national guideline for type 1 diabetes (2021 edition). Children’s doctors helped write it. International patients can get the treatments below at public hospitals. Which ones suit you is a decision for you and your doctor.

Standard care

Endocrinology departments diagnose diabetes, review your medicines and teach you how to manage it. They also check your eyes, kidneys, nerves and feet for damage.

Newer medicines

These newer medicines for diabetes are approved in China by its medicines regulator (NMPA). Each row links to the regulator’s own record. Other medicines are also used in China. This list shows only those we have checked in the regulator’s records.

Swipe the table sideways to see all columns.

MedicineWhat NMPA says (our translation)NMPA record
Semaglutide injection
司美格鲁肽注射液
Adults with type 2 diabetesApproved 2021 · report
Dulaglutide injection
度拉糖肽注射液
Type 2 diabetesReview passed: 2019 (NMPA)
PEG-loxenatide injection
聚乙二醇洛塞那肽注射液
Adults with type 2 diabetesApproved 2019
Dapagliflozin tablets
达格列净片
Type 2 diabetes, used on its ownDrug review report: 2017 (NMPA)
Henagliflozin tablets
脯氨酸恒格列净片
Adults with type 2 diabetes; developed in ChinaApproved 2021
Dorzagliatin tablets
多格列艾汀片
Adults with type 2 diabetesApproved 2022
Mulberry twig alkaloid tablets
桑枝总生物碱片
Type 2 diabetes, with diet and exerciseApproved 2020
Liraglutide injection
利拉鲁肽注射液
Type 2 diabetesImported registration 2011
Empagliflozin tablets
恩格列净片
Type 2 diabetes: added use with insulin, alongside diet and exerciseDrug review report: 2023 (NMPA)
Semaglutide tablets (oral)
司美格鲁肽片
Adults with type 2 diabetesDrug review report: 2024, first approval (NMPA)
Tirzepatide injection
替尔泊肽注射液
Adults with type 2 diabetes not controlled by diet and exercise plus metformin and/or a sulfonylureaDrug review report: 2024, first approval (NMPA)

Glucose monitors and insulin pumps

Glucose sensors from Chinese and foreign makers are registered in China. Examples are a sensor from MicroTech Medical for adults aged 18 and over (NMPA, 2021) and a sensor from Abbott (NMPA, 2023). A hybrid closed-loop insulin pump from Medtronic is approved for people with type 1 diabetes aged 14 and over (NMPA, 2023). It uses sensor readings to adjust the background (basal) insulin automatically, and the user can choose to give a mealtime dose.

Metabolic surgery

China’s national obesity treatment guideline (National Health Commission, 2024) supports surgery for some adults aged 18–70. For adults aged 18–70, its criteria include a BMI of 32.5 or more, or a BMI of 27.5 or more with type 2 diabetes. It also describes other situations. Some adults aged 18–70 have type 2 diabetes, a BMI from 25 to under 27.5, and blood sugar above target despite intensive medical treatment. For them, the guideline allows surgery only as research, with formal ethics approval and informed consent. It describes an assessment before surgery and a discussion between several specialists where needed.

What is not established care

In January 2025, China’s medicines regulator (NMPA) gave conditional approval to a stem-cell medicine, 艾米迈托赛注射液. It is approved for patients older than 14 with acute graft-versus-host disease that has not responded to steroids and mainly affects the gut. Diabetes is not an approved use. China’s rules forbid charging participants research-related fees in clinical studies of new biomedical technologies. Using such a technology as treatment needs separate approval from the national health authority (State Council Order No. 818, Articles 20 and 29; for stem cells, National Health Commission, 2015). Allogeneic islet transplantation (from a donor) is on China’s national list of restricted medical technologies. Hospitals that perform it must meet the national technical requirements (National Health Commission, 2022, G02). They must also file with the health authority within 15 working days after the first clinical use (medical technology rules, Article 11). Be cautious of any clinic that promises to “cure” diabetes.

This section is general information, not medical advice.

Reviewed by Dr. Arif Shah, MBBS · 2026-11-09.

Cost of diabetes care in China

Public hospital prices in China are set by each province, so the same service costs more in Beijing than in Sichuan. The figures below are official maximum prices at top-tier public hospitals in 12 provinces. Hospitals may charge less, but not more. Medicines, other tests, and international or VIP clinic fees are extra.

Swipe the table sideways to see all columns.

What a specialist visit costs, by doctor level (¥ per visit at top public hospitals; the dark mark is the typical price, the pale bar runs from the cheapest to the most expensive province)
Doctor levelTypicalRangeCheapest to most expensiveProvinces
Attending doctor¥12¥4–¥5012 provinces
Associate chief¥22¥8–¥6012 provinces
Chief physician¥31¥12–¥8012 provinces
Renowned expert¥79¥50–¥1188 provinces

Prices include the base fee and the extra charged for a senior doctor. In several provinces hospitals set the renowned-expert fee themselves, so fewer provinces publish it. Where a province lists several renowned-expert levels, we use the highest.

Swipe the table sideways to see all columns.

Common diabetes care items (typical price is the middle value across provinces; each row has its own unit)
ItemTypicalRangeUnitProvinces
HbA1c blood test¥30¥30–¥72per test12
Continuous glucose monitoring in hospital¥300¥240–¥600per session7
Continuous glucose monitoring in hospital¥150¥100–¥200per day2
Insulin pump therapy in hospital¥6.5¥4.7–¥10per hour4
Insulin pump therapy in hospital¥120¥70–¥150per day3
Hospital bed, shared room¥48¥30–¥60per day6
Hospital bed, three-bed room¥64¥40–¥70per day7
Hospital bed, two-bed room¥80¥60–¥90per day6
Single rooms are priced by each hospital, not by the province.

Example estimate: a chief physician visit plus an HbA1c test costs about ¥61 at typical prices (¥31 + ¥30). For your own case, check today’s fees in the hospital’s WeChat mini-program or ask us for a personal quote.

How we get these figures: every price comes from an official provincial medical price list, checked on 2026-11-07 (12 provinces). The typical price is the middle value when all provinces are lined up from cheapest to most expensive. This way, one very high or very low price does not distort it. “Provinces” shows how many published that price. These are maximum prices, and they change. Check the current fee in the hospital’s WeChat mini-program before you go.

Frequently asked questions

Which hospital is best for diabetes in China?

There is no official single best. Look for an endocrinology department the government has named a national clinical key specialty. Or look for a hospital that states its result in a national ranking for endocrinology. The tables above show both, with a link to each source. The best choice for you also depends on your type of diabetes, any complications and the city you can travel to.

How much does diabetes treatment cost in China?

At top public hospitals, a consultation typically costs about ¥12 with a standard doctor and ¥31 with a chief physician. An HbA1c test costs about ¥30, and a bed in a three-bed room about ¥64 a day. Medicines and other tests are extra. Send us your case for a personal quote.

Are semaglutide and other newer diabetes medicines available in China?

Yes. China’s medicines regulator has approved newer medicines for type 2 diabetes, such as semaglutide (injection and tablets), tirzepatide, liraglutide, dulaglutide, dapagliflozin and empagliflozin. It has also approved new medicines from Chinese companies, such as henagliflozin and dorzagliatin. Your doctor decides which, if any, suits you.

Can I have metabolic surgery for type 2 diabetes in China?

Yes, for adults who meet the national criteria: a BMI of 32.5 or more, or 27.5 or more with type 2 diabetes. Below that, surgery is allowed only as approved research. Both the endocrinology and surgery teams assess you first.

Did China reverse diabetes with stem cells?

No, not as an approved treatment. You may see news about stem-cell research for diabetes in China, but national rules say research results cannot be used directly as treatment. The stem-cell medicine China approved in 2025 is for a complication of transplants, not for diabetes. Be cautious of any clinic that offers stem cells for diabetes.

Is there care for type 1 diabetes, including children?

Yes, China has a national guideline for type 1 diabetes. Children’s doctors helped write it. A closed-loop insulin pump is approved for people with type 1 diabetes aged 14 and over.

Get help choosing a hospital

Tell us your diagnosis and recent test results. Our care team will suggest suitable hospitals from this list, explain the likely costs, and can arrange a medical interpreter in 48 Chinese cities.

WhatsApp Telegram Botim +880 1886 927106 WeChat ID alifa-health

WhatsApp and Telegram: +86 135 2232 3808. You can also use the live chat on this site at any time. We guide and arrange; treatment decisions stay with you and your doctors.